2017
Increasing Utilization of Stereotactic Radiation Therapy as a Component of Initial Therapy in Metastatic Non–small Cell Lung Cancer
Hayman T, Bledsoe T, Corso C, Lester-Coll N, Park H, Decker R. Increasing Utilization of Stereotactic Radiation Therapy as a Component of Initial Therapy in Metastatic Non–small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e459. DOI: 10.1016/j.ijrobp.2017.06.1702.Peer-Reviewed Original Research
2016
Receptor Tyrosine Kinases as Targets for Enhancing Tumor Radiosensitivity
Hayman T, Contessa J. Receptor Tyrosine Kinases as Targets for Enhancing Tumor Radiosensitivity. Cancer Drug Discovery And Development 2016, 35-55. DOI: 10.1007/978-3-319-40854-5_2.Peer-Reviewed Original ResearchReceptor tyrosine kinasesTumor radiosensitivityCombination of radiotherapyTyrosine kinaseMost solid tumorsField of oncologyClinical findingsClinical prognosisMaintenance/progressionIGF-1RRadiation therapyClinical investigationAforementioned receptorsSolid tumorsC-MetModest responseTherapyRadiation oncologyOncologyCancer therapyRadiotherapyAttractive targetRadiosensitivityCellular responsesAgents
2010
3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer
Chuong M, Hayman T, Patel M, Russell M, Malafa M, Hodul P, Springett G, Shridhar R, Hoffe S, Choi J. 3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s301. DOI: 10.1016/j.ijrobp.2010.07.715.Peer-Reviewed Original Research